Barbara Andraka-Christou, Ph.D., J.D., B.A.
Global Health Management and Informatics
Assistant Professor (Secondary Joint Appointment), College of Medicine, Department of Internal Medicine
Dr. Barbara “Basia” Andraka-Christou Barbara Andraka-Christou is an assistant professor in the School of Global Health Management and Informatics with a joint secondary appointment in the College of Medicine at UCF. Her research focuses on health services and health policies for expanding evidence-based treatment of substance use disorder. She also leads the UCF Court Health Services & Policies Workgroup and a Pre-Academia Mentoring Pod for female and minoritized PhD Students in Public Affairs.
Dr. Andraka-Christou’s work has been published in elite substance use and health policy journals, including Health Affairs, the International Journal of Drug Policy, the Journal of Substance Abuse Treatment, the Journal of Addiction Medicine, JAMA Network Open, and Substance Abuse. She has appeared on National Public Radio’s All Things Considered and Morning Edition. She is the author of the book The Opioid Fix: America’s Addiction Crisis and the Solution They Don’t Want You to Have (Johns Hopkins University Press, 2020). She is a licensed attorney in Florida.
Tuesday: 11 am – 2 pm
Thursday: 11 am – 1 pm
Postdoctoral fellowship in Public Health, Indiana University – Indianapolis, 2017
PhD in Law & Social Science, Indiana University – Bloomington, 2016
JD, Indiana University – Bloomington, 2013
BA in Economics, summa cum laude, University of Florida, 2008
- Health policy research, including using legal epidemiological methods
- Health services research, including mixed method program evaluation
- Evidence-based substance use disorder treatment
Research Method Expertise
- Operationalization of person-centered care
- Barriers & facilitators to using medications for opioid use disorder
- Problem-solving court policies
Current Research Topics
Won a bronze Independent Publisher Book Award (IPPY) from Independent Publisher Magazine for her solo-authored book, The Opioid Fix: America’s Addiction Crisis & the Solution they Don’t Want You to Have (June 2021), www.independentpublisher.com
Recent work was the subject of a published commentary in the flagship journal of Society of Addiction Medicine (Journal of Addiction Medicine): “The paper by Andraka-Christou and colleagues takes a giant step toward understanding differences, themes, and gaps in state policies.” (pubmed.ncbi.nlm.nih.gov)
Co-authored work cited by the Biden-Harris Administration’s Statement of Drug Policy Priorities for Year One. Executive Office of the President, Office of National Drug Control Policy: Washington, D.C.; 2021. Available at www.whitehouse.gov.
Selected for the NIH HEAL – JCOIN LEAP Investigator Program for 2021-2023
Early Career Investigator scholarship awarded to the 14th Academic and Health Policy Conference on Correctional Health. April 2021 (competitive scholarship) www.accjh.org
Andraka-Christou, B. (2021, Jun). Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder. Health Aff (Millwood), 40(6), 920-927. DOI
Andraka-Christou, B., Bouskill, K., Haffajee, R. L., Randall-Kosich, O., Golan, M., Totaram, R., Gordon, A. J., & Stein, B. D. (2021, Apr 28). Common themes in early state policy responses to substance use disorder treatment during COVID-19. Am J Drug Alcohol Abuse, 1-11. DOI
Andraka-Christou, B., Gordon, A. J., Bouskill, K., Smart, R., Randall-Kosich, O., Golan, M., Totaram, R., & Stein, B. D. (2021, May 18). Toward a Typology of Office-based Buprenorphine Treatment Laws: Themes from a Review of State Laws. J Addict Med. DOI
Andraka-Christou, B., Nguyen, T., Harris, S., Madeira, J., Totaram, R., Randall-Kosich, O., & Atkins, D. N. (2021, Feb 12). A pilot study of U.S. college students' 12-step orientation and the relationship with medications for opioid use disorder. J Am Coll Health, 1-9. DOI
Saloner, B., Andraka Christou, B., Gordon, A. J., & Stein, B. D. (2021, Apr 2). It will end in tiers: A strategy to include “dabblers” in the buprenorphine workforce after the X-waiver. Subst Abus, 1-5. DOI
Current Funded Projects
Bureau of Justice Administration 2019-AR-BX-K086, $1,492,871 (Kiel; Florida Office of the State Courts Administrator)
Enhancement & Evaluation for Florida’s Family Dependency Drug Courts
Role: Program Evaluator; Local PI (12.5% FTE each year for 3 years; $146,786 over 3 years; Project split at UCF = 50%)
NIH National Institute on Drug Abuse, 5R01DA045800-03 , $698,341 (Stein; Rand Corporation)
Quality of Medication Treatment for Opioid Use Disorder in Medicaid-Enrollees: The Effects of State Policies and Initiative.
Role: Coinvestigator; Local PI ($72,210 to date; 12% FTE; Project credit split at UCF 100% = $72,210)
- Elected Committee Member of the Behavioral Health Services Research Interest Group of Academy Health (national)
- Elected Board Member of Rebel Recovery LLC, a harm reduction/syringe exchange program in South Florida
- Subject Matter Expert for Project ECHO MAT Expansion at Arizona State University